Navigation Links
ePharmaSolutions' Clinical Trial Investigator Portal Wins Bio-IT World 2009 Best Practice Award
Date:4/30/2009

CONSHOHOCKEN, Pa., April 30 /PRNewswire/ -- ePharmaSolutions, a leading provider of clinical services and trial management technologies for the biopharmaceutical industry announced that it has been selected along with its client Genentech, Inc as the winner of the Bio-IT World Best Practice Award for it's Clinical Trial Portal solution. Winners were selected from 72 submissions in 7 categories by a peer reviewed panel of 14 expert judges. The ePharmaSolutions Clinical Trial Portal Solution won in the Clinical Trials Management category.

"We are absolutely thrilled that our application is recognized as the most innovative clinical trial management solution by such a distinguished panel of judges," stated Lance Converse, Founder and CEO of ePharmaSolutions. "We have worked exceptionally hard to develop solutions that help solve some of the industries biggest causes of study delays. This award validates our mission and strategy to provide to the industry with best in class solutions that facilitates ongoing communication and collaboration between all of the stakeholders in the clinical trial process," added Converse.

The Clinical Trial Portal was developed to provide pharmaceutical companies with a common technology platform to streamline and accelerate site selection, activation, training, patient recruitment and communication. In addition, the Clinical Trial Portal uses a federated user identity management model that provides users with one set of credentials across all sponsors to help reduce the amount of userIDs and passcodes that are typically required in this industry. The Clinical Trial Portal currently hosts 143,000 active clinical research users from 107 countries for the top 20 pharmaceutical companies in the world.

"To be selected along side such companies as Wyeth, GSK, Merck, Abbott and AstraZeneca is truly an honor," said Enrico DePaolis, President & Chief Operating Officer for ePharmaSolutions. "Our teams have been working exceptionally hard to develop solutions that meet our client needs, while ensuring they are simple and easy for sites to adopt and use. The credit really should go to them," added DePaolis.

In today's technology-driven clinical trials environment, sponsors and sites are required to use dozens of new technologies for every study they conduct, typically having to remember different user credentials for each technology. The Clinical Trial Portal helps streamline and systematize clinical trial workflow between sponsors and sites providing one userID and one URL for all of the studies they conduct while providing detailed and dashboard level reporting to help manage the entire process at the user, site, study and enterprise level.

About ePharmaSolutions, Inc.

ePharmaSolutions is a leading provider of technology-based clinical services that help improve the way sites are selected, trained, activated and supported to commence clinical trials and meet enrollment goals. ePharmaSolutions has activated and trained more than 143,000 clinical researchers in 107 countries for the top 20 pharmaceutical companies in the world. ePharmaSolutions is headquartered in Philadelphia, Pennsylvania. For more information call 610-832-9915 or visit www.epharmasolutions.com. For an interactive demonstration of the Clinical Trial Portal go to http://courses.epharmasolutions.com/diasomedemo/shortdemo.htm.


'/>"/>
SOURCE ePharmaSolutions
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
(Date:6/23/2016)... RIDGE, Ill. and INDIANAPOLIS ... of students receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship ... The 2016 scholarship winners, announced today online at ... to let type 1 diabetes stand in the way ... Diabetes has supported the Foundation,s scholarship program since 2012, ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop ... The fitness app plans to fix the two major problems leading the fitness industry today:, ... all type program , They don’t eliminate all the reasons people quit their ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... ... Bruton Memorial Library on June 21 due to a possible lice infestation, as reported by ... lice: the parasite’s ability to live away from a human host, and to infest common ... the event that lice have simply gotten out of control. , As lice are a ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
Breaking Medicine News(10 mins):